Clinical Impact of TP53 Disruption in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib: a Campus CLL Study
Leukemia(2023)
Key words
Preclinical research,Risk factors,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined